Using Machine Learning to Predict Remission in Patients With Major Depressive Disorder Treated With Desvenlafaxine

BACKGROUND: Major depressive disorder (MDD) is a common and burdensome condition that has low rates of treatment success for each individual treatment. This means that many patients require several medication switches to achieve remission; selecting an effective antidepressant is typically a sequent...

Descripción completa

Detalles Bibliográficos
Autores principales: Benoit, James R.A., Dursun, Serdar M., Greiner, Russell, Cao, Bo, Brown, Matthew R.G., Lam, Raymond W., Greenshaw, Andrew J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Regular Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8808003/
https://www.ncbi.nlm.nih.gov/pubmed/34379019
http://dx.doi.org/10.1177/07067437211037141

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8808003/
https://www.ncbi.nlm.nih.gov/pubmed/34379019
http://dx.doi.org/10.1177/07067437211037141

Ejemplares similares